About the journal

JAC-Antimicrobial Resistance (JAC-AMR) is a fully open access Society journal from the British Society for Antimicrobial Chemotherapy (BSAC).

As one of the most important threats to global health, antimicrobial resistance requires an innovative, interdisciplinary response. The mission of JAC-AMR is to disseminate cutting-edge research, and provide education regarding the origins, spread, characteristics, diagnosis, treatment, and prevention of multi-drug resistant organisms that result in difficult-to treat infections around the world.

We publish original research articles, reviews, clinically oriented opinions and viewpoints, debates, brief reports, and reviews of educational resources. JAC-AMR focuses on advancing the science and knowledge of antimicrobial resistance, stewardship and use relating to antibacterial, antifungal, antiviral and antiprotozoal agents. The Journal recognizes the importance of the “One Health” framework to understand AMR, and encourages AMR investigations that cover the spectrum of environment, animal and human health. JAC-AMR is dedicated to the dissemination of research on antimicrobial stewardship practices, and encourages the use of rigorous non-quantitative methodology where appropriate.

Publishing with JAC-Antimicrobial Resistance

As a JAC-AMR author, you support the British Society for Antimicrobial Chemotherapy (BSAC) and join a rich community dedicated to saving lives by fighting infection. BSAC members are eligible for a reduced APC, and APCs are waived for authors in developing countries and regions. JAC-AMR authors, reviewers, and editors are part of a forward-thinking, innovative community with a focus on scientific excellence and interdisciplinary approaches to advancing our field.

A global audience for your work

JAC-AMR connects powerful ideas with the widest audience to give your research the greatest possible impact. Our top regions for readership are Europe, North America, and China.  

• 20,400+ average monthly article downloads in 2022 and growing rapidly

• Discoverable in PubMed (full text for all articles directly available in PubMed Central), Web of Science Emerging Sources Citation Index, Scopus, and the Directory of Open Access Journals

• Promotion through JAC-AMR’s growing social media presence (make sure you’re following us on Twitter: @jac_amr)

• Publishing in JAC-AMR gets your work noticed! 94% of articles published in 2022 have been mentioned online, including in news outlets, social media, patents, and government policy documents*.

*Source: Altmetric, May 2023

Efficient and transparent editorial processes

When you submit a manuscript to JAC-AMR, you can be confident that the support of our editorial team and our rigorous peer review process will ensure that your research findings are published at their best.

Editorial decision-making is managed by a team of active researchers, clinicians, and academics whose expertise represents the antimicrobial resistance research community.

Manuscript processing times:

• 33 days from submission to first decision

• 12 days in review

• 13 days from acceptance to publication

Abstracting and Indexing Services

JAC-AMR is covered by the following major indexing services:

• PubMed Central® (PMC)
• PubMed®
• Scopus
• Emerging Sources Citation Index (ESCI)

Journal CiteScore

• 5.3

Impact Factor and Ranking

Latest information taken from the Journal Citation Reports™ from Clarivate, 2024.